OncoSec Medical is a biopharmaceutical company engaged in developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies for the treatment of solid tumor cancers and metastatic disease. Addressing an unmet medical need, OMS ElectroOncology therapies represent a potential solution for less invasive and lower-cost therapies that can minimize the detrimental effects of presently available cancer treatments like surgery, systemic chemotherapy, or immunotherapy and other treatment alternatives. For more information visit the company’s Web site at www.oncosec.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: